These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39395052)

  • 1. Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry.
    Tuderti G; Mastroianni R; Proietti F; Wu Z; Wang L; Franco A; Abdollah F; Finati M; Ferro M; Tozzi M; Porpiglia F; Checcucci E; Bhanvadia R; Margulis V; Bronimann S; Singla N; Hakimi K; Derweesh IH; Correa A; Helstrom E; Mendiola DF; Gonzalgo ML; David RB; Mehrazin R; Moon SC; Rais-Bahrami S; Yong C; Sundaram CP; Tufano A; Perdonà S; Ghoreifi A; Moghaddam FS; Djaladat H; Ditonno F; Antonelli A; Autorino R; Simone G
    World J Urol; 2024 Oct; 42(1):575. PubMed ID: 39395052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM
    J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
    Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
    Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
    Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
    Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
    Takahashi K; Urabe F; Suhara Y; Nakano J; Yoshihara K; Goto Y; Sadakane I; Koike Y; Yata Y; Suzuki H; Kurawaki S; Miyajima K; Iwatani K; Imai Y; Sakanaka K; Nakazono M; Kurauchi T; Kayano S; Onuma H; Aikawa K; Yanagisawa T; Tashiro K; Tsuzuki S; Koike Y; Furuta A; Miki J; Kimura T
    Jpn J Clin Oncol; 2023 Dec; 53(12):1208-1214. PubMed ID: 37647644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
    Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
    Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
    Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
    Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant Systemic Therapy Improved Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Di Bello F; Jannello LMI; Siech C; de Angelis M; Rodriguez Peñaranda N; Tian Z; Goyal JA; Ruvolo CC; Califano G; Creta M; Morra S; Saad F; Shariat SF; de Cobelli O; Briganti A; Chun FKH; Puliatti S; Longo N; Karakiewicz PI
    Ann Surg Oncol; 2024 Oct; 31(10):7229-7236. PubMed ID: 39031261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma.
    Gin GE; Ruel NH; Kardos SV; Sfakianos JP; Uchio E; Lau CS; Yuh BE
    Urol Oncol; 2017 May; 35(5):192-200. PubMed ID: 28041996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
    Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
    J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.
    Martini A; Falagario UG; Waingankar N; Daza J; Treacy PJ; Necchi A; Galsky MD; Sfakianos JP
    Urol Oncol; 2020 Aug; 38(8):684.e9-684.e15. PubMed ID: 32284255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
    Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
    Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes.
    Chakiryan N; Martinez A; Gao L; Liu JJ; Amling C; Garzotto M; Kopp RP
    J Urol; 2019 Jul; 202(1):76-82. PubMed ID: 30925108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.